Vice Chair, Global Health
Professor, Global Health
EducationMD Medicine, University of Washington, 2003
PhD Epidemiology, University of Washington, 2001
BA Chemistry, Religious Studies, Washington University, 1995
Ninth and Jefferson Building 12th Floor
908 Jefferson Street
Seattle, WA 98104
Dr. Baeten's research focuses on the prevention of HIV-1 and other sexually transmitted diseases, including clinical trials of novel prevention interventions, epidemiologic studies of risk factors for HIV-1 transmission, and behavioral, translational, and implementation science research aimed at optimizing prevention delivery. He led the Partners PrEP Study and MTN-020/ASPIRE, randomized clinical trials that demonstrated the efficacy of oral tenofovir-based pre-exposure prophylaxis (PrEP) and the dapivirine vaginal ring for protection against HIV-1 acquisition. Current projects include a) a multinational open-label trial of the dapivirine vaginal ring for HIV-1 prevention in women (MTN-025/HOPE, through the NIH Microbicides Trials Network), b) implementation science work to deliver antiretroviral treatment and PrEP for HIV-1 prevention, c) studies exploring use of hormonal contraception as a risk factor for HIV-1 (including co-chairing the ECHO Study), and d) collaborative studies of immunologic and virologic factors that influence HIV-1 transmission. He also directs the UW/Fred Hutch Center for AIDS Research (CFAR).
- HIV/AIDS and other STDs
In The News
How does PrEP, the HIV-prevention medication, work?
Live Science, 08/12/2018
Open-label studies show high uptake of vaginal ring for HIV prevention
Vaginal ring has high uptake, but plenty of questions remain
MD Mag, 03/15/2018